Drug Shortage Report for MYLAN-LOSARTAN
Report ID | 3335 |
Drug Identification Number | 02368277 |
Brand name | MYLAN-LOSARTAN |
Common or Proper name | Losartan |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | LOSARTAN POTASSIUM |
Strength(s) | 25MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100BT, 30 BL |
ATC code | C09CA |
ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-07-03 |
Actual start date | 2018-07-03 |
Estimated end date | 2018-08-10 |
Actual end date | 2018-08-10 |
Shortage status | Resolved |
Updated date | 2018-08-11 |
Company comments | Discontinued in report 53729 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-03-17 | English | Compare |
v2 | 2017-03-17 | French | Compare |
v3 | 2017-03-23 | English | Compare |
v4 | 2017-03-23 | French | Compare |
v5 | 2017-04-26 | English | Compare |
v6 | 2017-05-02 | English | Compare |
v7 | 2017-05-02 | French | Compare |
v8 | 2017-05-03 | English | Compare |
v9 | 2017-05-03 | French | Compare |
v10 | 2017-05-08 | English | Compare |
v11 | 2017-05-10 | English | Compare |
v12 | 2017-05-10 | French | Compare |
v13 | 2017-05-25 | English | Compare |
v14 | 2017-05-25 | French | Compare |
v15 | 2017-05-25 | English | Compare |
v16 | 2017-05-25 | French | Compare |
v17 | 2018-06-05 | English | Compare |
v18 | 2018-06-05 | French | Compare |
v19 | 2018-07-03 | English | Compare |
v20 | 2018-07-03 | French | Compare |